Feature | Nick Obradovich and Dave Fornell
February 9, 2009 - Biosense Webster Inc. said Friday the FDA granted market clearance for the NaviStar ThermoCool Catheter for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible 3D electroanatomic mapping systems.
February 09, 2009
News
February 9, 2009 - Implantation of drug-eluting stents to treat degenerative in aortocoronary saphenous vein graft (SVG) lesions is safe, according to a study published in the Jan. 15 issue of the American Journal of Cardiology (Vol. 103, issue 2, Pages 199-202).
February 09, 2009
News
February 9, 2009 – Some patients who suffer a stroke as a result of a blockage in an artery in the brain may benefit from a clot-busting drug nine or more hours after the onset of symptoms, according to findings published in the online edition of Radiology.
February 09, 2009Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
February 9, 2009 - Emory University cardiologists are testing a modification of angioplasty known as postconditioning, designed to reduce permanent damage to the heart muscle after a heart attack.
February 08, 2009
Technology
February 6, 2009 - Biosense Webster Inc., a Johnson & Johnson company, today said the FDA granted market approval to the NaviStar ThermoCool Catheter for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible 3D electroanatomic mapping systems.
February 06, 2009Technology
February 6, 2009 – The FDA has approved St. Jude Medical Inc.’s medical device system that allows a single defibrillation lead connection between a cardiac resynchronization therapy defibrillator (CRT-D) and the leads that send electrical impulses to the heart to treat the symptoms of heart failure.
February 06, 2009Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature
February 6, 2009 - Medtronic Inc. today said it completed the acquisition of Ablation Frontiers Inc. for an initial payment of $225 million plus potential additional payments contingent upon achievement of certain clinical milestones.
February 06, 2009
News
February 6, 2009 - Boston Scientific Corp. yesterday submitted to the FDA the final modules of the company’s pre-market approval (PMA) applications for both its TAXUS Liberte Atom Paclitaxel-Eluting Coronary Stent System and its TAXUS Liberte Long Paclitaxel-Eluting Coronary Stent System.
February 06, 2009
News
February 6, 2009 - Premier Purchasing Partners yesterday announced new agreements for drug-eluting coronary stents with Abbott Laboratories Inc., Abbott Vascular and Cordis Corp. The 13-month agreements went into effect Jan. 1, 2009 and are available to acute care and continuum of care members of the Premier healthcare alliance.
February 06, 2009Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
February 5, 2009 - Resuscitation device maker ZOLL Medical Corp. said this week it filed a lawsuit against Alsius Corp. and Alsius Medical Corp. in the Central District of California alleging infringement of its patents for catheter-based induced hypothermia devices.
February 05, 2009
News
February 5, 2009 - BeneChill Inc. this week started the PRINCE (Pre-Resuscitation Intra-Nasal Cooling Effectiveness) study, a randomized study to determine whether intra-nasal cooling using the RhinoChill device during resuscitation increases patient and survival rates, including ischemic events such as cardiac arrest and stroke.
February 05, 2009
News
February 5, 2009 - AGA Medical Corp. last week said following its previous favorable structural heart occluder patent infringement final ruling by the German court of appeals over Occlutech GmbH of Jena, Germany, it has calculated and notified Occlutech of the amount of damages that it will seek from Occlutech based on the court’s ruling.
February 05, 2009Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature
February 4, 2009 – The Medical Imaging & Technology Alliance (MITA) endorses policies that ensure medical imaging is utilized appropriately and that unnecessary scans are reduced.
February 04, 2009
Technology
February 4, 2009 - Calgary Scientific Inc. launched the multi patent-pending PureWeb Platform, a medical application platform designed to enable both Calgary Scientific’s ResolutionMD products and third-party applications to be delivered over the web.
February 04, 2009News
February 4, 2009 — Early registration for the 2009 Annual Healthcare Information and Management Systems Society Conference & Exhibition (HIMSS 2009) is running ahead of the 2008 trend, which ended with a record 29,174 attendees, according to HIMSS.
February 04, 2009© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now